Diagnostic Histopathology
Volume 15, Issue 9 , Pages 444-453 , September 2009

The surgical pathology of skeletal metastases

References 

  1. Yochum TR, Rowe LJ. Tumor and tumor-like processes. In:  Yochum TR,  Rowe LJ editor. Essentials of skeletal radiology. vol. 2:Baltimore: Williams and Wilkins; 1987;p. 699–919
  2. Berrettoni BA, Carter JR. Mechanisms of cancer metastasis to bone. J Bone Joint Surg Am. 1986;68:308–312
  3. Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;350:1655–1664
  4. Tokuhashi Y, Ajiro Y, Umezawa N. Outcome of treatment for spinal metastases using scoring system for preoperative evaluation of prognosis. Spine. 2009;34:69–73
  5. Coleman RE. Bisphosphonates: clinical experience. Oncologist. 2004;9(Suppl. 4):14–27
  6. Batson O. The role of the vertebral veins in the metastatic processes. Ann Intern Med. 1942;16:38–45
  7. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571–573
  8. Hart IR, Fidler IJ. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res. 1980;40:2281–2287
  9. Leeson MC, Makley JT, Carter JR. Metastatic skeletal disease in the pediatric population. J Pediatr Orthop. 1985;5:261–267
  10. Tanabe M, Ohnuma N, Iwai J, et al. Bone marrow metastasis of neuroblastoma analyzed by MRI and its influence on prognosis. Med Pediatr Oncol. 1995;24:292–299
  11. Berthold F, Hero B, Breu H, et al. The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients. Ann Oncol. 1996;7:183–187
  12. Bachman AS, Sproul EE. Correlation of radiographic and autopsy findings in suspectewd metastases in the spine. Bull NY Acad Med. 1940;44:169–175
  13. Tins BJ, Cassar-Pullicino VN, Lalam R, Tyrrell PNM. In:  Davies AM,  Murali Sundaram M,  James SLJ editor. Imaging of bone tumors and tumor-like lesions: techniques and applications. Berlin: Springer; 2009;Chapter 27 – Bone metastases 2: Appendicular skeleton and pelvis.
  14. Tyrrell PNM, Cassar-Pullicino VN, Lalam R, Tins BJ. In:  Davies AM,  Murali Sundaram M,  James SLJ editor. Imaging of bone tumors and tumor-like lesions: techniques and applications. Berlin: Springer; 2009;Chapter 27 – Bone metastases 1: Spine
  15. Holmes FF, Fouts TL. Metastatic cancer of unknown primary site. Cancer. 1970;26:816–820
  16. Lleander VC, Goldstein G, Horsley JS. Chemotherapy in the management of metastatic cancer of unknown primary site. Oncology. 1972;26:265–270
  17. Didolkar MS, Fanous N, Elias EG, Moore RH. Metastatic carcinomas from occult primary tumors. A study of 254 patients. Ann Surg. 1977;186:625–630
  18. Destombe C, Botton E, Le Gal G, et al. Investigations for bone metastasis from an unknown primary. Joint Bone Spine. 2007;74:85–89
  19. Simon MA, Bartucci EJ. The search for the primary tumor in patients with skeletal metastases of unknown origin. Cancer. 1986;58:1088–1095
  20. Nottebaert M, Exner GU, von Hochstetter AR, Schreiber A. Metastatic bone disease from occult carcinoma: a profile. Int Orthop. 1989;13:119–123
  21. Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. J Bone Joint Surg Am. 1993;75:1276–1281
  22. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403–439
  23. Mizutani Y, Nakajima T, Morinaga S, et al. Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Special reference to nonmucus producing lung adenocarcinomas. Cancer. 1988;61:532–537
  24. Bejarano PA, Nikiforov YE, Swenson ES, Biddinger PW. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol. 2000;8:189–194
  25. Fabbro D, Di Loreto C, Stamerra O, Beltrami CA, Lonigro R, Damante G. TTF-1 gene expression in human lung tumours. Eur J Cancer. 1996;32A:512–517
  26. Mazoujian G, Pinkus GS, Davis S, Haagensen DE. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol. 1983;110:105–112
  27. Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol. 1989;20:281–287
  28. Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303–310
  29. Lugli A, Tornillo L, Mirlacher M, Bundi M, Sauter G, Terracciano LM. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples. Am J Clin Pathol. 2004;122:721–727
  30. Fan Z, van de Rijn M, Montgomery K, Rouse RV. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol. 2003;16:137–144
  31. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962–972
  32. Perry A, Parisi JE, Kurtin PJ. Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Hum Pathol. 1997;28:938–943
  33. Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simoes M. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol. 2000;190:437–443
  34. Lagendijk JH, Mullink H, Van Diest PJ, Meijer GA, Meijer CJ. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol. 1998;29:491–497
  35. Kaufmann O, Deidesheimer T, Muehlenberg M, Deicke P, Dietel M. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology. 1996;29:233–240
  36. Loy TS, Quesenberry JT, Sharp SC. Distribution of CA125 in adenocarcinomas. An immunohistochemical study of 481cases. Am J Clin Pathol. 1992;98:175–179
  37. Frierson HF, Moskaluk CA, Powell SM, et al. Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas. Hum Pathol. 2003;34:605–609
  38. Ordonez NG. Application of mesothelin Immunostaining in tumor diagnosis. Am J Surg Pathol. 2003;27:1418–1428
  39. Moskaluk CA, Zhang H, Powell SM, Cerilli LA, Hampton GM, Frierson HF. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol. 2003;16:913–919
  40. Brown RW, Campagna LB, Dunn JK, Cagle PT. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. Am J Clin Pathol. 1997;107:12–19
  41. Zamecnik J, Kodet R. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Virchows Arch. 2002;440:353–361
  42. Wang Z, Spaulding B, Sienko A, et al. Mammaglobin, a valuable diagnostic marker for metastatic breast carcinoma. Int J Clin Exp Pathol. 2009;2:384–389
  43. Dennis JL, Hvidsten TR, Wit EC, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 2005;11:3766–3772
  44. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology – Occult Primary version 1. Available from: http://www.nccn.org/professionals/physician_gls/PDF/occult.pdf2009;
  45. Monzon FA, Lyons-Weiler M, Buturovic LJ, et al. Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin. J Clin Oncol. 2009;27:1–13
  46. Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26:462–469

PII: S1756-2317(09)00128-5

doi: 10.1016/j.mpdhp.2009.06.003

Diagnostic Histopathology
Volume 15, Issue 9 , Pages 444-453 , September 2009

Article Tools

* Image Usage & Resolution